N
NAMS
NewAmsterdam Pharma Company N.V
34.76
-0.31-0.88%After Hours: 34.76 0.00 0.00%16:10 04/10 EDT
OPEN/PREV CLOSE35.44/35.07
TODAY RANGE34.54-35.44
VOL547.26K
MARKET CAP4.00B
52 WEEK RANGE14.06-42.00
AVG VOL (3M)788.93K
% TURNOVER0.48%
TURNOVER--
P/E (TTM)-20.1964
% RANGE2.57%
EPS(TTM)-1.7211
P/E(FORWARD)-13.9902
P/B5.82
BVPS5.97
DIVIDEND--
P/S176.72
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.37B
SHARES OUTSTANDING114.98M
NEXT EARNINGS05/06-05/11
FREE FLOAT96.87M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·04/02 11:45
NewAmsterdam Pharma Company (NAMS) Receives a Buy from Wells Fargo
TipRanks·03/18 19:50
NewAmsterdam Pharma initiated with a Buy at Truist
Seeking Alpha·03/18 05:35
AMG TimesSquare Small Cap Growth Fund Q4 2025 Performance Insights
TipRanks·03/13 02:08
NewAmsterdam Pharma Director Makes Major Stock Move in High-Value Sale
TipRanks·03/03 02:10
Massive Insider Move at NewAmsterdam Pharma Shakes Up Investor Buzz
TipRanks·03/02 13:43
NewAmsterdam Highlights Obicetrapib Progress in Investor Presentation
TipRanks·02/25 02:06
Top Executive Makes Bold Move With Major NewAmsterdam Pharma Stock Sale
NASDAQ·02/23 15:40
Interesting NAMS Put And Call Options For July 17th
Dow Jones·02/19 14:42
NewAmsterdam Pharma Is Maintained at Buy by Guggenheim
Dow Jones·02/19 14:42
NewAmsterdam Pharma Price Target Raised to $45.00/Share From $41.00 by Guggenheim
Benzinga·02/19 14:32
Guggenheim Maintains Buy on NewAmsterdam Pharma Co, Raises Price Target to $45
TipRanks·02/19 13:51
NewAmsterdam Pharma management to meet virtually with Piper Sandler
TipRanks·02/19 12:29
NewAmsterdam Pharma Company (NAMS) Receives a Buy from RBC Capital